AUG 11, 2026 · PHASE 2 TRIAL
Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC
ClinicalTrials.gov
This is a Phase 2 registry record for an unstarted trial with planned enrollment of 15 participants; no results are posted, making it early-stage feasibility work.
Reported
Planned enrollment15
Phase2
Primary outcome measureSafety (SAE, AE), from enrollment to end of…